Beyond nine lives
Longevity medicines for cats
Cats age too quickly.
By the time most people notice their cat is getting older, it’s already too late to intervene. Age-related decline has set in: loss of muscle mass, mobility, organ function, cognitive changes, and a drop in quality of life. This isn’t just heartbreaking, it’s unnecessary.
At The Cat Health Company, we believe aging is a biological process that can be slowed, paused, even reversed.
We’re building the first longevity medicines for cats.
In silico strategies for feline longevity
Through computational modeling, machine learning algorithms, and in silico prediction, we are designing and optimising evidence-based medicines that address the molecular mechanisms of aging in cats.
Why cats?
Cats are family. Yet while human medicine has made huge strides, our cats are still underserved. Most medications focus on symptoms, not the root causes of aging.
We’re changing that.
By treating the biology of aging itself, we aim to delay disease onset, extend healthy lifespan and improve quality of life in senior cats.
Cats are a unique model for human aging
We believe cats deserve more, and that solving aging in cats will help us solve it everywhere.
Shared environment
They share our homes, lifestyles, and many diseases.
Faster discovery
Shorter lifespans allow us to see effects faster.
Broader applications
In both veterinary and human medicine.
Pipeline
We develop therapeutic programs using our in-house SOTA ML models and lab validations, some of which have reached clinical stages and out-licensing.
About us
Our world-class team of scientists, clinicians and pharma industry experts are leading the mission to go beyond just nine lives.
Alex Voda, DPhil
Co-founder & CEO - Doctorate in Molecular and Cellular Medicine from the University of Oxford, previously led projects at Genevia Technologies and biotech startups
Alex Bacita, BSc
Co-founder & COO - University of Manchester almnus, previously senior scientist and project lead in pharma, worked at Biorelate, Labcorp, Charles River Labs in drug discovery roles
Cristina Alexandru, PhD
Scientist - Previously worked on molecular genetics at The University of Manchester and in cellular senescence with Verdin lab at The Buck Institute for Aging
Justina Duagi, DVM
Vet Lead - Manages patient recruitment for the clinical studies, validates eligibility against the protocol and coordinates contact with the owners throughout
Ioana Marian, DVM
Vet Lead - Coordinates clinical partnerships and clinical assessment during the studies and connecting what is observed in practice back to the research
Andrei Ion, MA
Media Manager - Responsible for the company's brand and external communication across press, web and investor materials
Vlad Ungureanu, PhD
Senior Bioinformatician - Builds and maintains the drug-discovery pipeline, runs all statistical analysis and translation between species
Izabela Geanta, MSc
Bioinformatician - Protein structure prediction, docking and molecular dynamics. Internal clinical-data platform management that consolidates longitudinal records
Mihai Tanase, Esq
Counsel & external legal coordinator - Previously assisting on legal matters and interactions with regulatory agencies for NGOs and parliament senators
